Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Operations

v3.20.1
Consolidated Statement of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]    
Revenue $ 129,558 $ 77,845
Cost of revenue 103,205 62,425
Gross profit 26,353 15,420
Operating expenses:    
Research and development 5,310 3,368
Sales and marketing 6,031 6,313
General and administrative 17,431 11,359
Loss on equity investments   (95)
Total operating expenses 28,772 20,945
Loss from operations (2,419) (5,525)
Other income, net 136 297
Financial expense, net (439) (416)
Foreign currency loss (517) (32)
Loss before income tax expense (3,239) (5,676)
Income tax expense 2,273 1,424
Net loss (5,512) (7,100)
Net loss attributable to non-controlling interests   (2)
Net loss attributable to the owners of the parent (5,512) (7,098)
Net loss attributable to common stockholders $ (5,512) $ (7,100)
Net loss per share attributable to common stockholders, basic and diluted [1] $ (0.48) $ (0.72)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted [1] 11,603,381 9,828,411
[1] Amounts for the year ended December 31, 2018 differ from those published in prior year consolidated financial statements as they were retrospectively adjusted as a result of the accounting for the Business Combination (as defined below in the notes). Specifically, the number of common shares outstanding during periods before the Business Combination are computed on the basis of the number of common shares of Kaleyra S.p.A. (accounting acquiror) during those periods multiplied by the exchange ratio established in the stock purchase agreement. Common stock and additional paid-in capital were adjusted accordingly